PROJECT
Remote monitoring of heart failure patients
Need
Remote patient monitoring (RPM) allows early detection and treatment of complications in cardiovascular diseases. This is the case of intravascular sensors for chronic heart failure patients. These patients are monitored by evaluating symptoms, weight and biomarkers, but this is often inadequate as they occur late in the decompensation process, which leads them to hospitalizations. Each episode contributes to a decrease in the overall cardiac function, resulting in a chronic decline that worsens the health of the patient and damages vital organs.
If heart failure patients are correctly monitored and treated, they improve their clinical status, functional capacity and quality of life. This prevents hospital readmission, reducing their mortality probability. This would also result in a decrease of the socioeconomic costs associated with this cardiovascular condition.
Implantable RPM systems anticipate complications of the decompensation process, but current injectable devices rely on a single biomedical parameter. A combination of parameters could complement the congestion monitoring, resulting in a smarter assessment. This can be accomplished by FORESEE.
Our solution
FORESEE is a novel microsensing platform for RPM. It is based on an innovative wireless power transfer and communications method developed for neuroprosthetics: the eAXON technology. This technology avoids the use of bulky components within the implant, accomplishing ultrathin and flexible electronic implants for biomedical applications. Our microsensing platform will result in wireless intravascular sensors that can perform smart assessment for RPM in several cardiovascular conditions, starting with chronic heart failure.
